Tango Therapeutics, Inc. (TNGX) Earnings
Tango Therapeutics, Inc. is expected to report next earnings on August 4, 2026 (in NaN days), with a consensus EPS estimate of $-0.31. TNGX has beaten EPS estimates in 3 of its last 7 reported quarters (average surprise +299.9% over the last four).
Next earnings
Aug 4, 2026in NaN days
EPS est $-0.31 · Revenue est $2M
Track record
Beat EPS in 3 of 7 quarters
Avg surprise +299.9% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 13, 2026 | $-0.32 | $-0.32 | +0.0% | — | — |
| Mar 5, 2026 | $-0.32 | $-0.29 | +8.9% | — | — |
| Nov 4, 2025 | $0.01 | $0.13 | +1200.0% | $54M | +9578.2% |
| Feb 27, 2025 | $-0.32 | $-0.35 | -9.4% | $4M | -48.6% |
| Mar 18, 2024 | $-0.28 | $-0.32 | -14.3% | $5M | -34.1% |
| Nov 10, 2022 | $-0.32 | $-0.33 | -3.1% | $7M | +22.6% |
| Aug 10, 2022 | $-0.33 | $-0.28 | +15.2% | $6M | +2.0% |
| Aug 6, 2021 | — | $-0.05 | — | $18M | — |
| Mar 31, 2021 | — | $-0.42 | — | $9M | — |
| Nov 13, 2020 | — | $-0.31 | — | $11M | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.